P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000971592.88393.d2 |
| _version_ | 1797280161659355136 |
|---|---|
| author | LI Zhi-Ming Peng Sun Hong Cen Hai-Yan Yang Rui Huang Zhen Cai Xue-Kui Gu |
| author_facet | LI Zhi-Ming Peng Sun Hong Cen Hai-Yan Yang Rui Huang Zhen Cai Xue-Kui Gu |
| author_sort | LI Zhi-Ming |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:36:14Z |
| format | Article |
| id | doaj.art-4d3140bfc57b4d1caba13543bbce8666 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:36:14Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-4d3140bfc57b4d1caba13543bbce86662024-03-03T09:43:15ZengWileyHemaSphere2572-92412023-08-017e88393d210.1097/01.HS9.0000971592.88393.d2202308003-01072P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGYLI Zhi-Ming0Peng Sun1Hong Cen2Hai-Yan Yang3Rui Huang4Zhen Cai5Xue-Kui Gu61 Sun Yat-sen University Cancer Center, Department of Medical Oncology, Guangzhou, China1 Sun Yat-sen University Cancer Center, Department of Medical Oncology, Guangzhou, China2 Guangxi Medical University Affiliated Tumor Hospital, Department of Lymphohematology and Pediatric Oncology, Nanning, China3 Zhejiang Cancer Hospital, Department of Lymphoma, China4 Zhujiang Hospital of Southern Medical University, Department of Hematology, China5 The First Affiliated Hospital of Zhejiang University School of Medicine, Bone Marrow Transplantation Center of Hematology Department, China6 The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Department of Hematology, Chinahttp://journals.lww.com/10.1097/01.HS9.0000971592.88393.d2 |
| spellingShingle | LI Zhi-Ming Peng Sun Hong Cen Hai-Yan Yang Rui Huang Zhen Cai Xue-Kui Gu P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY HemaSphere |
| title | P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title_full | P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title_fullStr | P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title_full_unstemmed | P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title_short | P1174: PI3K INHIBITOR LINPERLISIB COMBINED WITH GEMCITABINE AND OXALIPATIN (GEMOX) IN RELAPSED AND/OR REFRACTORY DLBCL: ANALYSIS BASED ON TUMOR BIOLOGY |
| title_sort | p1174 pi3k inhibitor linperlisib combined with gemcitabine and oxalipatin gemox in relapsed and or refractory dlbcl analysis based on tumor biology |
| url | http://journals.lww.com/10.1097/01.HS9.0000971592.88393.d2 |
| work_keys_str_mv | AT lizhiming p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT pengsun p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT hongcen p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT haiyanyang p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT ruihuang p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT zhencai p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology AT xuekuigu p1174pi3kinhibitorlinperlisibcombinedwithgemcitabineandoxalipatingemoxinrelapsedandorrefractorydlbclanalysisbasedontumorbiology |